Arbutus Biopharma ABUS Earnings Call Transcripts

NASDAQ ABUS
$3.83 +0.11 (+2.82%)
As of: Nov 10, 2026 · 3:59 PM EST
7 earnings calls on file for Arbutus Biopharma, from Q4 2020 to Q2 2022. Each transcript opens in a new tab.
Latest earnings call

Arbutus Biopharma Q2 2022 Earnings Call

Aug 4, 2022 4,668 words · 20 min read
  • Lisa CaperelliVice President, Investor Relations
  • Bill CollierPresident and Chief Executive Officer
  • Dave HastingsChief Financial Officer
  • Gaston PicchioChief Development Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Arbutus Biopharma Earnings Call Transcripts

Calls7
LatestAug 4, 2022
SinceQ4 2020

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 7 Arbutus Biopharma transcripts Register to get access to Arbutus Biopharma’s earnings call transcripts.